Analyst Consensus ?
ConsensusBuy61 ratings
Bullish4472.1%
Neutral1524.6%
Bearish23.3%
FN2 Earnings Intelligence
Halliburton Company (HAL) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Jul 27, 2026 |
| Argus Research | Buy | Buy | Maintain | Jul 23, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 22, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 22, 2026 |
| Freedom Broker | Hold | Sell | Upgrade | Jul 22, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 22, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 22, 2026 |
| Piper Sandler | Overweight | Neutral | Upgrade | Jul 14, 2026 |
| Susquehanna | Positive | Positive | Maintain | Jul 8, 2026 |
| Citigroup | Buy | Buy | Maintain | Jun 3, 2026 |
| Stifel | Buy | Buy | Maintain | Apr 22, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Apr 22, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Apr 22, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Mar 25, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jan 22, 2026 |
| Freedom Capital Markets | Sell | Hold | Downgrade | Jan 6, 2026 |
| HSBC | Buy | Hold | Upgrade | Oct 22, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 23, 2025 |
| Benchmark | Buy | Buy | Maintain | Jan 23, 2025 |
| Jefferies | Buy | Buy | Maintain | Jan 3, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Nov 8, 2024 |
| B of A Securities | Buy | Buy | Maintain | Oct 14, 2024 |
| Wolfe Research | Outperform | Underperform | Upgrade | Jan 12, 2023 |
| Stephens & Co. | Equal Weight | Overweight | Downgrade | Apr 20, 2022 |
| BNP Paribas | Neutral | Underperform | Upgrade | Jul 21, 2021 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 22, 2021 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Jan 25, 2021 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Jul 15, 2020 |
| Northland Capital Markets | Perform | Market Perform | Maintain | May 29, 2020 |
| Bernstein | Perform | Market Perform | Maintain | Jan 14, 2020 |
| Scotiabank | Sector Outperform | Sector Perform | Upgrade | Jan 6, 2020 |
| Deutsche Bank | Buy | Buy | Maintain | Nov 20, 2019 |
| Bank of America | Buy | Buy | Maintain | Sep 5, 2019 |
| Societe Generale | Buy | Hold | Upgrade | Dec 20, 2018 |
| Cleveland Research | Neutral | Buy | Downgrade | Oct 18, 2018 |
| Stifel Nicolaus | Buy | Buy | Maintain | Sep 11, 2018 |
| Argus | Hold | Hold | Maintain | May 5, 2018 |
| Guggenheim | Buy | Neutral | Upgrade | Jan 22, 2018 |
| Loop Capital | Buy | Buy | Maintain | Oct 24, 2017 |
| Seaport Global | Neutral | Buy | Downgrade | Jun 21, 2017 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jan 18, 2017 |
| Nomura | Buy | Buy | Maintain | Oct 20, 2016 |
| iBERIA Capital Partners | Outperform | Outperform | Maintain | Oct 20, 2016 |
| DA Davidson | Buy | Buy | Maintain | Oct 19, 2016 |
| FBR Capital | Outperform | Outperform | Maintain | Jul 21, 2016 |
| Griffin Securities | Buy | Buy | Maintain | May 19, 2016 |
| KLR Group | Buy | Accumulate | Maintain | Jan 28, 2016 |
| Baird | Neutral | Neutral | Maintain | Jan 26, 2016 |
| Keybanc | Overweight | Sector Weight | Upgrade | Jan 5, 2016 |
| GMP Securities | Buy | Buy | Maintain | Jan 5, 2016 |
| Macquarie | Neutral | Neutral | Maintain | Oct 20, 2015 |
| Oppenheimer | Outperform | Outperform | Maintain | Oct 1, 2015 |
| CLSA | Underperform | Outperform | Downgrade | Apr 20, 2015 |
| ISI Group | Buy | Buy | Maintain | Oct 16, 2014 |
| Drexel Hamilton | Buy | Buy | Maintain | Jun 20, 2014 |
| Global Hunter Securities | Neutral | Buy | Downgrade | Nov 18, 2013 |
| MLV & Co. | Buy | Hold | Upgrade | Jan 28, 2013 |
| Dahlman Rose | Buy | Buy | Maintain | Jan 28, 2013 |
| Standpoint Research | Hold | Buy | Downgrade | Jan 8, 2013 |
| Pritchard Capital Partners | Buy | Buy | Maintain | Apr 19, 2012 |
| Bank oferica | Buy | Buy | Maintain | Apr 19, 2012 |
Upside is calculated against the persisted current price $31.64. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Josh Silverstein | $39 | $32.7 | +23.3% | Jul 27, 2026 |
| Argus Research | Bill Selesky | $40 | $33.68 | +26.4% | Jul 23, 2026 |
| BMO Capital | Analyst unavailable | $37 | $33.22 | +17.0% | Jul 22, 2026 |
| Evercore ISI | Stephen Richardson | $43 | $33.52 | +35.9% | Jul 22, 2026 |
| Barclays | Analyst unavailable | $53 | $33.19 | +67.5% | Jul 22, 2026 |
| Morgan Stanley | Analyst unavailable | $41 | $35.52 | +29.6% | Jul 15, 2026 |
| Piper Sandler | Analyst unavailable | $43 | $35.21 | +35.9% | Jul 14, 2026 |
| Susquehanna | Analyst unavailable | $42 | $33.79 | +32.8% | Jul 8, 2026 |
| UBS | Analyst unavailable | $40 | $33.24 | +26.4% | Jul 2, 2026 |
| Barclays | Analyst unavailable | $55 | $40.4 | +73.9% | May 7, 2026 |
| Jefferies | Analyst unavailable | $47 | $40.36 | +48.6% | Apr 26, 2026 |
| Morgan Stanley | Analyst unavailable | $40 | $37.51 | +26.4% | Apr 15, 2026 |
| Barclays | Analyst unavailable | $29 | $37.69 | -8.3% | Apr 9, 2026 |
| Jefferies | Analyst unavailable | $39 | $33.84 | +23.3% | Feb 6, 2026 |
| UBS | Analyst unavailable | $35 | $34.56 | +10.6% | Jan 23, 2026 |
| BMO Capital | Analyst unavailable | $39 | $33.72 | +23.3% | Jan 23, 2026 |
| RBC Capital | Keith Mackey | $38 | $33.08 | +20.1% | Jan 22, 2026 |
| Evercore ISI | Jason Bandel | $36 | $32.94 | +13.8% | Jan 22, 2026 |
| Stifel Nicolaus | Analyst unavailable | $36 | $33.55 | +13.8% | Jan 22, 2026 |
| Goldman Sachs | Neil Mehta | $40 | $33.55 | +26.4% | Jan 22, 2026 |
| Susquehanna | Charles Minervino | $40 | $33.36 | +26.4% | Jan 22, 2026 |
| Morgan Stanley | Analyst unavailable | $35 | $33.25 | +10.6% | Jan 21, 2026 |
| Stifel Nicolaus | Analyst unavailable | $35 | $33.38 | +10.6% | Jan 21, 2026 |
| RBC Capital | Keith Mackey | $36 | $32.8 | +13.8% | Jan 15, 2026 |
| Goldman Sachs | Analyst unavailable | $35 | $32.61 | +10.6% | Jan 14, 2026 |
| Piper Sandler | Derek Podhaizer | $30 | $32.61 | -5.2% | Jan 14, 2026 |
| Susquehanna | Analyst unavailable | $36 | $30.62 | +13.8% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $35 | $31.92 | +10.6% | Jan 6, 2026 |
| Piper Sandler | Analyst unavailable | $29 | $27.74 | -8.3% | Dec 18, 2025 |
| Morgan Stanley | Analyst unavailable | $34 | $28.32 | +7.5% | Dec 15, 2025 |
| UBS | Analyst unavailable | $32 | $28.74 | +1.2% | Dec 12, 2025 |
| Redburn Partners | Sebastian Erskine | $35 | $26.84 | +10.6% | Nov 3, 2025 |
| Goldman Sachs | Analyst unavailable | $28 | $26.31 | -11.5% | Oct 23, 2025 |
| Barclays | David Anderson | $25 | $27.04 | -21.0% | Oct 23, 2025 |
| UBS | Analyst unavailable | $24 | $26.14 | -24.1% | Oct 22, 2025 |
| Piper Sandler | Derek Podhaizer | $27 | $25.24 | -14.7% | Oct 22, 2025 |
| Susquehanna | Analyst unavailable | $29 | $25.24 | -8.3% | Oct 22, 2025 |
| Stifel Nicolaus | Stephen Gengaro | $32 | $25.24 | +1.2% | Oct 22, 2025 |
| HSBC | Analyst unavailable | $30 | $25.24 | -5.2% | Oct 22, 2025 |
| RBC Capital | Keith Mackey | $31 | $25.24 | -2.0% | Oct 22, 2025 |
| Barclays | Analyst unavailable | $20 | $22.5 | -36.8% | Oct 14, 2025 |
| UBS | Analyst unavailable | $23 | $24.31 | -27.3% | Oct 6, 2025 |
| Wells Fargo | Roger Read | $27 | $20.61 | -14.7% | Apr 23, 2025 |
| Griffin | Kevin Simpson | $28 | $26.08 | -11.5% | Dec 20, 2024 |
| Wells Fargo | Roger Read | $39 | $29.97 | +23.3% | Sep 24, 2024 |
| Jefferies | Lloyd Byrne | $46 | $29.97 | +45.4% | Sep 24, 2024 |
| RBC Capital | Sector Perform | $37 | $28.02 | +17.0% | Sep 13, 2024 |
| Barclays | David Anderson | $48 | $33.39 | +51.7% | Jul 23, 2024 |
| Stifel Nicolaus | Stephen Gengaro | $45 | $33.39 | +42.2% | Jul 22, 2024 |
| Susquehanna | Charles Minervino | $46 | $34.02 | +45.4% | Jul 22, 2024 |
| Evercore ISI | James West | $48 | $33.99 | +51.7% | Jul 22, 2024 |
| Piper Sandler | Luke Lemoine | $40 | $34.4 | +26.4% | Jul 22, 2024 |
| RBC Capital | Keith Mackey | $44 | $34.4 | +39.1% | Jul 22, 2024 |
| Evercore ISI | James West | $52 | $34.4 | +64.4% | Jul 19, 2024 |
| Wolfe Research | Sam Margolin | $52 | $38.79 | +64.4% | Apr 23, 2024 |
| Raymond James | Praveen Narra | $49 | $37.01 | +54.9% | Jul 20, 2023 |
| Wells Fargo | Christopher Voie | $33 | $29.3 | +4.3% | Jul 30, 2022 |
| Barclays | David Anderson | $50 | $35.62 | +58.1% | Apr 29, 2022 |
| HSBC | Abhishek Kumar | $41.6 | $35.94 | +31.5% | Apr 28, 2022 |
| RBC Capital | Keith Mackey | $49 | $35.16 | +54.9% | Apr 25, 2022 |
| Susquehanna | Charles Minervino | $48 | $39.6 | +51.7% | Apr 20, 2022 |
| Citigroup | Analyst unavailable | $48 | $39.89 | +51.7% | Apr 20, 2022 |
| Stephens | Analyst unavailable | $40 | $39.47 | +26.4% | Apr 20, 2022 |
| Stifel Nicolaus | Stephen Gengaro | $42 | $39.06 | +32.8% | Apr 11, 2022 |
| Morgan Stanley | Connor Lynagh | $45 | $39.06 | +42.2% | Apr 11, 2022 |
| BMO Capital | Phillip Jungwirth | $32 | $30.48 | +1.2% | Jan 25, 2022 |
| RBC Capital | Keith Mackey | $34 | $30.59 | +7.5% | Jan 25, 2022 |
| Cowen & Co. | Marc Bianchi | $35 | $30.48 | +10.6% | Jan 25, 2022 |
| Stephens | Tommy Moll | $38 | $30.48 | +20.1% | Jan 25, 2022 |
| Griffin | Kevin Simpson | $32 | $23.9 | +1.2% | Jan 3, 2022 |
| Benchmark Co. | Douglas Becker | $31 | $21.92 | -2.0% | Nov 19, 2021 |
| Barclays | David Anderson | $36 | $26.31 | +13.8% | Oct 20, 2021 |
| Argus Research | Bill Selesky | $32 | $26.31 | +1.2% | Oct 20, 2021 |
| Coker Palmer | Vaibhav Vaishnav | $24 | $24.36 | -24.1% | Oct 12, 2021 |
| HSBC | Abhishek Kumar | $18.2 | $19.33 | -42.5% | Aug 5, 2021 |
| Piper Sandler | Ian Macpherson | $25.5 | $20.61 | -19.4% | Jul 21, 2021 |
| Goldman Sachs | Neil Mehta | $26 | $20.61 | -17.8% | Jul 21, 2021 |
| BNP Paribas | Nick Konstantakis | $23 | $20.61 | -27.3% | Jul 21, 2021 |
Track every rating change on HAL the moment it posts. Free to start.
Start free